U.S. attorney investigating quality issues at St. Louis EpiPen plant, Pfizer says

Pfizer Inc. said Thursday it received a request for documents as part of a U.S. investigation into quality issues involving the manufacture of auto-injectors at its Meridian Medical Technologies site, in St. Louis. The demand was from the U.S. Attorney's office for the Southern District of New York, Pfizer said, according to Reuters. The news agency reports that Pfizer unit Meridian, which makes the EpiPen injectors used to deliver an emergency allergy antidote, has been hit with manufacturing…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news